Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis

Clinical Endocrinology

Volumn 62, Issue 4, 2005, Pages 509-511

  Oler, Gisele ^a   Ebina, Katia N ^b   Michaluart Jr , Pedro ^b   Kimura, Edna T ^b   Cerutti, Janete ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ARTICLE; GENE MUTATION; GENE SEQUENCE; LYMPH NODE; LYMPH NODE METASTASIS; PAPILLARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID CARCINOMA; THYROID GLAND;

CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; HUMANS; LYMPHATIC METASTASIS; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 17044395065     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02235.x     Document Type: Article

References (8)

1. Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W.H., Ladenson, P.W. & Sidransky, D. (2003) BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute, 95, 625-627.
2. Kimura, E.T., Nikiforova, M.N., Zhu, Z., Knauf, J.A., Nikiforov, Y.E. & Fagin, J.A. (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research, 63, 1454-1457.
3. Kimura, E.T., Vanvooren, V., van Sande, J., Nikiforov, Y.E. & Fagin, J.A. (2004) Autonomously functioning thyroid nodules are not associated with BRAF mutations. Clinical Endocrinology (Oxford), 60, 394-396.
4. Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T.I., Ohtsuru, A., Saenko, V.A., Kanematsu, T. & Yamashita, S. (2003) Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism, 88, 4393-4397.
5. Nikiforova, M.N., Kimura, E.T., Gandhi, M., Biddinger, P.W., Knauf, J.A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., Santoro, M., Fagin, J.A. & Nikiforov, Y.E. (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Journal of Clinical Endocrinology and Metabolism, 88, 5399-5404.
6. Nakabashi, C.C., Guimaraes, G.S., Michaluart, P. Jr, Ward, L.S., Cerutti, J.M. & Maciel, R.M. (2004) The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma. Clinical Endocrinology (Oxford), 61, 280-282.
7. Sedliarou, I., Saenko, V., Lantsov, D., Rogounovitch, T., Namba, H., Abrosimov, A., Lushnikov, E., Kumagai, A., Nakashima, M., Meirmanov, S., Mine, M., Hayashi, T. & Yamashita, S. (2004) The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. International Journal of Oncology, 25, 1729-1735.
8. Vogelstein, B. & Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nature Medicine, 10, 789-799.